Telomere attrition—gradual loss of chromosome caps—links to heart disease, immune decline, and frailty. Explore new data, lifestyle levers, and emerging therapies.
In a May 7, 2024 press release, Seragon Biosciences announced that its aging intervention drug candidate, SRN-901, achieved one of the largest extensions of